InsiderTrades.com logo
We recommended Palantir in 2021, now we’re recommending this...
From Behind the Markets   |   Ad
My research indicates there is only one investment that can meet AI's unprecedented demand for energy.
Click to get the name and ticker symbol
Erez Raphael net worth and biography
  • LinkedIn
  • Phone
  • Email
  • Website

Erez Raphael Biography and Net Worth

CEO of DarioHealth
Currently, Erez Raphael is Chief Executive Officer & Director at DarioHealth Corp.

In the past Mr. Raphael was Head-Business Operations at Nokia Siemens Networks Israel Ltd.

He received an undergraduate degree from the University of Haifa.

What is Erez Raphael's net worth?

The estimated net worth of Erez Raphael is at least $1.36 million as of August 27th, 2024. Mr. Raphael owns 1,937,059 shares of DarioHealth stock worth more than $1,355,748 as of December 26th. This net worth approximation does not reflect any other investments that Mr. Raphael may own. Additionally, Mr. Raphael receives a salary of $722,190.00 as CEO at DarioHealth. Learn More about Erez Raphael's net worth.

How old is Erez Raphael?

Mr. Raphael is currently 51 years old. There are 3 older executives and no younger executives at DarioHealth. Learn More on Erez Raphael's age.

What is Erez Raphael's salary?

As the CEO of DarioHealth Corp., Mr. Raphael earns $722,190.00 per year. Learn More on Erez Raphael's salary.

How do I contact Erez Raphael?

The corporate mailing address for Mr. Raphael and other DarioHealth executives is 8 HaToKhen Street, Caesarea Industrial Park L3, 3088900. DarioHealth can also be reached via phone at (833) 914-3796 and via email at [email protected]. Learn More on Erez Raphael's contact information.

Has Erez Raphael been buying or selling shares of DarioHealth?

Erez Raphael has not been actively trading shares of DarioHealth during the last quarter. Most recently, on Tuesday, August 27th, Erez Raphael bought 5,000 shares of DarioHealth stock. The stock was acquired at an average cost of $0.88 per share, with a total value of $4,400.00. Following the completion of the transaction, the chief executive officer now directly owns 1,937,059 shares of the company's stock, valued at $1,704,611.92. Learn More on Erez Raphael's trading history.

Who are DarioHealth's active insiders?

DarioHealth's insider roster includes Dror Bacher (COO), Oded Cohen (Insider), Dennis McGrath (Director), and Erez Raphael (CEO). Learn More on DarioHealth's active insiders.

Are insiders buying or selling shares of DarioHealth?

In the last year, DarioHealth insiders bought shares 4 times. They purchased a total of 20,000 shares worth more than $16,500.00. The most recent insider tranaction occured on September, 11th when insider Steven Charles Nelson bought 5,000 shares worth more than $4,000.00. Insiders at DarioHealth own 16.5% of the company. Learn More about insider trades at DarioHealth.

Information on this page was last updated on 9/11/2024.

Erez Raphael Insider Trading History at DarioHealth

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/27/2024Buy5,000$0.88$4,400.001,937,059View SEC Filing Icon  
1/13/2023Sell1,200$6.21$7,452.001,112,059View SEC Filing Icon  
11/8/2021Sell800$19.08$15,264.00View SEC Filing Icon  
11/3/2021Sell30,483$18.96$577,957.68View SEC Filing Icon  
11/1/2021Sell25,804$18.01$464,730.04View SEC Filing Icon  
7/15/2021Sell1,300$17.63$22,919.00943,299View SEC Filing Icon  
6/9/2020Buy1,000$6.05$6,050.00
3/25/2020Buy1,000$6.50$6,500.00
8/28/2019Buy10,000$0.35$3,500.00View SEC Filing Icon  
11/20/2018Buy4,000$0.84$3,360.00View SEC Filing Icon  
8/19/2016Buy500$3.57$1,785.00111,129View SEC Filing Icon  
See Full Table

Erez Raphael Buying and Selling Activity at DarioHealth

This chart shows Erez Raphael's buying and selling at DarioHealth by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

DarioHealth Company Overview

DarioHealth logo
DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, pre-diabetes, hypertension, and weight management; Dario Move, which address most common musculoskeletal conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; and Dario One, a full suite of chronic condition management solution; and Dario blood glucose monitoring systems. It also provides native devices, such as glucose meter, blood pressure cuff, digital scale, and biofeedback sensor device, as well as live coaching services. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
Read More

Today's Range

Now: $0.70
Low: $0.68
High: $0.74

50 Day Range

MA: $0.83
Low: $0.65
High: $1.03

2 Week Range

Now: $0.70
Low: $0.65
High: $2.60

Volume

142,726 shs

Average Volume

115,458 shs

Market Capitalization

$23.86 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.47
$19 for a FULL YEAR of stock picks?!
From Behind the Markets   |   Ad
We're offering you the chance to subscribe to Behind the Markets for an ENTIRE YEAR for just $19. But why? Because there is a very small window of time... as little as 25 days from now... That will change the market forever.
Click here to get in now>>>